Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer in treating high cholesterol, it said.
An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...
Pharmaceutical companies have spent years targeting a common blood particle associated with heart-attack risks.
One and done? Pharma giant Eli Lilly announced Monday that its gene-editing therapy can reduce LDL (“bad”) cholesterol by up ...
Regular follow-up calls from a pharmacist can help people lower their "bad" (LDL) cholesterol by reminding them to take their ...
More than 140,000 bottles of a widely prescribed cholesterol medication have been pulled from the market after failing to meet quality standards. Ascend Laboratories of New Jersey issued the recall ...
Stopping cholesterol medication midway may seem harmless - especially when your reports look better, and you feel fine. But doctors warn this decision can trigger a dangerous “silent rebound,” where ...
The FDA said that nearly 142,000 bottles were recalled because of failed dissolution specifications, meaning the medication did not dissolve as it should have, and may not work as effectively, Fox ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results